Astellas Pharma (United States)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (United States), United States, covering academic research published from 2005 to 2023. Read More.
Open Access Percentage
59%
Total
Publications
1.5K
Total Open
Publications
891
Total
Citations
41K
Open Access
Percentage
59%
Total
Publications
1.5K
Total Open
Publications
891
Total
Citations
41K
Breakdown
Publisher Open
25%
Both
29%
Other Platform Open
5%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
187
Hybrid 48%
391
No Guarantees 29%
232
Other Platform Open
Domain 92%
477
Institution 17%
88
Public 9%
47
Other Internet 6%
33
Preprint 0%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 477 |
Europe PMC | Domain | 258 |
Semantic Scholar | Public | 33 |
DOI | Other Internet | 32 |
Figshare | Public | 31 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 12 |
California Digital Library - eScholarship | Other Internet | 12 |
University of California - eScholarship University of California | Institution | 10 |
KU Leuven - Lirias | Institution | 10 |
University College London - UCL Discovery | Institution | 8 |